<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01608789</url>
  </required_header>
  <id_info>
    <org_study_id>SU012</org_study_id>
    <nct_id>NCT01608789</nct_id>
  </id_info>
  <brief_title>Virtue® European Study</brief_title>
  <official_title>Virtue® Male Sling European Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, single arm, non-randomized, multi-center clinical study that
      will be conducted in Europe. It is designed to assess efficacy and safety of the Virtue® Male
      Sling in post-prostatectomy urinary incontinence.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 27, 2012</start_date>
  <completion_date type="Anticipated">June 5, 2018</completion_date>
  <primary_completion_date type="Actual">June 28, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of urinary incontinence based on 24-hour pad test</measure>
    <time_frame>1 year</time_frame>
    <description>The primary effectiveness end point will be improvement in pad weight defined as at least a 50% reduction in 24-hour pad weight from baseline to 12-months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety of the device characterized by reported adverse events</measure>
    <time_frame>1 year</time_frame>
    <description>Safety of the device, including the implant procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement of urinary incontinence based on 24-hour pad test</measure>
    <time_frame>Baseline, 1 month, 3 months, 6 months, 2 years, 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of urinary incontinence based on number of pad used</measure>
    <time_frame>baseline,1 month, 3 months, 6 months, 1 year, 2 years and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject reported improvement measured by the PGI-I</measure>
    <time_frame>1 month, 3 months, 6 months, 1 year, 2 years, 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the frequency, severity and impact on quality of life of urinary incontinence based on ICIQ-UI short form</measure>
    <time_frame>baseline, 1 months, 3 months, 6 months, 1 year, 2 years and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction questionaire</measure>
    <time_frame>1 month, 3 months, 6 months, 1 year, 2 years, 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety of the device characterized by reported adverse events</measure>
    <time_frame>Intraoperative, 1 month, 3 months, 6 months, 2 years, 3 years</time_frame>
    <description>Safety of the device, including the implant procedure.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">123</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Virtue® Male Sling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Virtue® Male Sling</intervention_name>
    <description>The Coloplast Virtue® Male Sling is a Class II, implantable, sub-urethral, permanent, non-absorbable support sling indicated for the surgical treatment of male stress urinary incontinence (SUI) resulting from intrinsic sphincter deficiency (ISD).</description>
    <arm_group_label>Virtue® Male Sling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The subject has an estimated life expectancy of more than 5 years

               -  The subject has confirmed stress urinary incontinence (SUI) through medical
                  history, urodynamics, and/or physical exam for at least 6 months

               -  The subject has intrinsic sphincter deficiency due to radical prostatectomy
                  completed at least 1 year prior to implantation date

               -  The subject has a good bladder function

               -  The subject has failed non-invasive therapies, eg. Pelvic Floor/Kegel exercises,
                  behavioral modification, or biofeedback, for at least 6 months

               -  The subject is willing to have the Virtue® Male Sling implanted

               -  The subject is able and willing to complete all follow-up visits and procedures
                  indicated in this protocol

        Exclusion Criteria:

          -  The subject is unable or unwilling to comply with all follow-up requirements according
             to the study protocol

               -  The subject has an active urinary tract infection or active skin infection in
                  region of surgery (temporary exclusion)

               -  The subject has compromised immune systems or any other conditions that affect
                  healing

               -  The subject has serious bleeding disorders

               -  The subject has an urinary incontinence that is not mainly a stress urinary
                  incontinence

               -  The subject has a stress urinary incontinence due to TransUrethral Resection or
                  laser surgery of the Prostate (TURP)

               -  The subject has incontinence due to neurogenic causes defined as multiple
                  sclerosis, spinal cord/brain injury, CVA, detrusor-external sphincter
                  dyssynergia, Parkinson's disease, or similar conditions

               -  The subject had a previous implant (male sling, Artificial Urinary Sphincter) to
                  treat stress urinary incontinence (previous implanted bulking agents are allowed)

               -  The subject has undergone radiation, cryosurgery, or brachy therapy to treat
                  prostate or other pelvic cancer within 6 months

               -  The subject is likely to undergo radiation therapy within the next 3 months

               -  The subject has a postvoid residual (PVR) &gt; or = 150mL

               -  The subject has recently required transurethral instrumentation for urethral or
                  urethro-vesical anatomosis stricture within the previous 6 months

               -  The subject is enrolled in a concurrent clinical study of any treatment (drug or
                  device) that could affect continence function without the sponsors' approval

               -  The subject is deemed unfit for male sling implantation or participation in a
                  research protocol as determined by the attending physician
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital Erasme</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Gent</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalo Universitaire Carémeau</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heilig Geist Krankenhaus</name>
      <address>
        <city>Köln</city>
        <zip>50737</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mater Private Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto europeo di Oncologia</name>
      <address>
        <city>Milan</city>
        <zip>20141</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Maria della Misericordia</name>
      <address>
        <city>Udine</city>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <zip>23000</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacio Puigvert - Universitat Autonoma de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>0825</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta del Mar</name>
      <address>
        <city>Cádiz</city>
        <zip>11009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guy's Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2012</study_first_submitted>
  <study_first_submitted_qc>May 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 31, 2012</study_first_posted>
  <last_update_submitted>January 24, 2018</last_update_submitted>
  <last_update_submitted_qc>January 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Male sling</keyword>
  <keyword>Stress Urinary Incontinence</keyword>
  <keyword>Urination Disorders</keyword>
  <keyword>Urologic Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

